Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.41)
# 970
Out of 4,479 analysts
57
Total ratings
47.92%
Success rate
4.08%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $7.02 | +56.70% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $6.85 | +337.96% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $6.10 | +162.30% | 3 | Sep 14, 2023 | |
| RCM R1 RCM | Initiates: Overweight | $20 | $10.90 | +83.49% | 3 | Aug 15, 2023 | |
| AMWL American Well | Initiates: Overweight | n/a | $0.30 | - | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | n/a | $85.76 | - | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $26.16 | - | 2 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | n/a | $53.77 | - | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | n/a | $10.51 | - | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | n/a | $19.25 | - | 2 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | n/a | $9.40 | - | 7 | Apr 15, 2020 | |
| MDRX Veradigm | Reiterates: Neutral | n/a | $9.66 | - | 3 | Mar 3, 2020 | |
| EHTH eHealth | Reiterates: Overweight | n/a | $4.46 | - | 2 | Feb 21, 2020 | |
| CI Cigna | Reiterates: Overweight | n/a | $325.91 | - | 1 | Feb 6, 2020 | |
| HUM Humana | Reiterates: Overweight | n/a | $374.82 | - | 1 | Feb 5, 2020 | |
| PHR Phreesia | Initiates: Overweight | n/a | $20.50 | - | 1 | Jan 9, 2020 | |
| CNC Centene | Maintains: Overweight | n/a | $66.19 | - | 3 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $7.02
Upside: +56.70%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $6.85
Upside: +337.96%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $6.10
Upside: +162.30%
R1 RCM
Aug 15, 2023
Initiates: Overweight
Price Target: $20
Current: $10.90
Upside: +83.49%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: n/a
Current: $0.30
Upside: -
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $85.76
Upside: -
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $26.16
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: n/a
Current: $53.77
Upside: -
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: n/a
Current: $10.51
Upside: -
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $19.25
Upside: -
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: n/a
Current: $9.40
Upside: -
Veradigm
Mar 3, 2020
Reiterates: Neutral
Price Target: n/a
Current: $9.66
Upside: -
eHealth
Feb 21, 2020
Reiterates: Overweight
Price Target: n/a
Current: $4.46
Upside: -
Cigna
Feb 6, 2020
Reiterates: Overweight
Price Target: n/a
Current: $325.91
Upside: -
Humana
Feb 5, 2020
Reiterates: Overweight
Price Target: n/a
Current: $374.82
Upside: -
Phreesia
Jan 9, 2020
Initiates: Overweight
Price Target: n/a
Current: $20.50
Upside: -
Centene
Dec 17, 2018
Maintains: Overweight
Price Target: n/a
Current: $66.19
Upside: -